Global Oxygen Therapy Market By Oxygen Source Equipment (Oxygen Concentrators, Compressed Oxygen Cylinders, Liquid Oxygen Systems) ; By Oxygen Delivery Devices (Oxygen Masks, Bag Valve Masks, Nasal Cannulas, Venturi Mask, and others); By End Users (Hospitals & Clinics, Home Healthcare, Rehabilitation Centers, By Application( COPD (Chronic Obstructive Pulmonary Disease), Asthma, Sleep Apnea, Respiratory Distress Syndrome(RDS), Cystic Fibrosis); By Region (U.S., Canada, Mexico, Rest of North America, France, The UK, Spain, Germany, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2018 – 2026

Report ID :AMI-250 | Category : Healthcare | Published Date : July, 2019 | Pages : 385 | Format :PDF

Industry Trends

Oxygen therapy refers to the treatment concerned with providing required oxygen to patients suffering from various breathing disorders such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, cystic fibrosis and pneumonia amongst others. The therapy assists patients suffering from hypoxemia and improve their quality of living. The types of systems through which oxygen is delivered include oxygen concentrators, compressed oxygen cylinder and liquid oxygen cylinder. Compressed and liquid oxygen cylinders are stationary oxygen tanks and are heavier due to their high storage capacity whereas concentrators are lighter, electrically chargeable and mobile. The adoption of oxygen concentrators is more dominant among patients owing to its portability characteristic. Additionally, increase in prevalence of chronic respiratory diseases is further supplementing the growth of oxygen therapy market. Lack of adequate skillsets to effectively diagnose, prevent and manage COPD across both, rural and urban areas along with high developmental cost of advanced and innovative devices are critically impacting the market growth in low-middle income countries.

In 2018, World Health Organization (WHO), reported that about nine out of ten people were inhaling contaminated air, and was also identified as the main reason for death of about 7 million lives annually. A majority of premature death in Europe is attributed to the alarming presence of fine particulate matter (PM2.5), nitrogen dioxide (NO2) and ozone (O3) in the air causing asthma, lung cancer and heart diseases. European Environment Agency (EEA) reported that the peril has impacted about 40 countries in Europe. Air pollution is thus identified as among the major concern triggering respiratory diseases, and is thereby contributing towards the growth of oxygen therapy market.

Medical equipment such as oxygen masks, bag valve masks, and nasal cannulas are being widely used in oxygen delivery system. Market participants are engaging in developing innovative healthcare solutions in this regard. In June 2019, ZOLL Medical Corporation, manufacturer of innovative medical equipment and developer of related software solutions, acquired TherOx, Inc., a medical device company, to include supersaturated oxygen therapy (SSO2) into their product portfolio. The therapy is mainly focused towards the treatment of acute myocardial infarction (AMI), thereby subsiding the impact on heart tissue. The additional development in the technology aims to find applications in various other physiologic areas. Hence, such advancements in healthcare remedies are supplementing the growth of oxygen therapy market.

North America region holds the largest market share in the global oxygen therapy market, owing to the availability of well-equipped infrastructure and greater adoption of advanced technology. Massive investments being made into further advancement of the technology has propelled the expansion of the market in the region. Oxypoint, a Europe-based medical device company, offers

O2COMFORT flowmeter which enables constant and convenient inhalation of one to five litres of oxygen per minute, thereby aiding in reduced wastage as compared to the traditional flowmeter.

The company obtained its first round of funding of about USD 4.28 Million in 2018 towards the development of medical devices for oxygen therapy in hospitals. The company is further focusing towards expanding its commercial footprint in East and North America. The oxygen therapy market in Asia Pacific is anticipated to be the most attractive market owing to faster adoption of advance technologies in China, India and Japan.

The global oxygen therapy market revenue stood at US$ 9399.1 million in 2018, and is expected to grow with a CAGR of over 10.9% during the forecast period of 2019 - 2027. The study analyzes the market in terms of revenue across all the major markets.

Global Oxygen Therapy Market Revenue (US$ Million), 2015 – 2027

Competitive Landscape

The report provides both, qualitative and quantitative research of global oxygen therapy market, as well as provides worthy insights into the rational scenario and favored development methods adopted by key contenders. The report also offers extensive research on the key players in global oxygen therapy market and detailed insights on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their headquarters, competitors, product/service type, application and specification, pricing, and gross margin.

The primary market participants in the global oxygen therapy market include 3M, General Electric Company, Koninklijke PhilipsN.V., Chart, DeVilbiss Healthcare, Essex Industries, Inc., Fisher & Paykel Healthcare Limited, Inogen, Inotec AMD Limited., Invacare Corporation, VitalAire, Teleflex Incorporated, ResMed, O2 CONCEPTS, LLC, OxyBand Technologies, Nidek Medical Products Inc., and MAQUET Holding B.V. & Co.KG amongst others.

Click on image to enlarge

Global Oxygen Therapy Market (2015 – 2027)

By Oxygen Source Equipment
- Oxygen Concentrators
- Compressed Oxygen Cylinders
- Liquid Oxygen Systems
By Oxygen Delivery Devices
- Oxygen Masks
- Bag Valve Masks
- Nasal Cannulas
- Venturi Mask
- Others
By End Users
- Hospitals & Clinics
- Home Healthcare
- Rehabilitation Centers
By Application
- COPD (Chronic Obstructive Pulmonary Disease)
- Asthma
- Sleep Apnea
- Respiratory Distress Syndrome (RDS)
- Cystic Fibrosis
- Pneumonia
- Others
By Region
- North America
  - U.S.
  - Canada
  - Mexico
  - Rest of North America
- Europe
  - France
  - The UK
  - Spain
  - Germany
  - Italy
  - Nordic Countries
    - Denmark
    - Finland
    - Iceland
    - Sweden
    - Norway
  - Benelux Union
    - Belgium
    - The Netherlands
    - Luxembourg
  - Rest of Europe
- Asia Pacific
  - China
  - Japan
  - India
  - New Zealand
  - Australia
  - South Korea
  - Southeast Asia
    - Indonesia
    - Thailand
    - Malaysia
    - Singapore
    - Rest of Southeast Asia
  - Rest of Asia Pacific
- Middle East & Africa
  - Saudi Arabia
  - UAE
  - Egypt
  - Kuwait
  - South Africa
  - Rest of Middle East & Africa
- Latin America
  - Brazil
  - Argentina
  - Rest of Latin America

1. Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2013 - 2017

1.2.2. Base Year: 2018

1.2.3. Forecast Years: 2019 – 2027

2. Key Target Audiences

3. Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4. Recommendations and Insights from AMI’s Perspective**

5. Holistic Overview of Oxygen Therapy Market

6. Market Synopsis: Oxygen Therapy Market

7. Oxygen Therapy Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.2.4. Challenges

7.3. Trends in Oxygen Therapy Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Oxygen Therapy Market

7.6. Industry Gross Margin Overview

7.7. Porter’s Five Force Analysis

8. Global Oxygen Therapy Market Analysis and Forecasts, 2019 – 2027

8.1. Overview

8.1.1. Global Oxygen Therapy Market Revenue (US$ Mn)

8.2. Global Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

8.2.1. Oxygen Concentrators

8.2.1.1. Definition

8.2.1.2. Market Penetration, 2018

8.2.1.3. Market Estimation, 2013 – 2018

8.2.1.4. Market Forecast, 2019 – 2027

8.2.1.5. Compound Annual Growth Rate (CAGR)

8.2.1.6. Regional Bifurcation

8.2.1.6.1. North America

8.2.1.6.1.1.Market Estimation, 2013 – 2018

8.2.1.6.1.2.Market Forecast, 2019 – 2027

8.2.1.6.2. Europe

8.2.1.6.2.1.Market Estimation, 2013 – 2018

8.2.1.6.2.2.Market Forecast, 2019 – 2027

8.2.1.6.3. Asia Pacific

8.2.1.6.3.1.Market Estimation, 2013 – 2018

8.2.1.6.3.2.Market Forecast, 2019 – 2027

8.2.1.6.4. Middle East and Africa

8.2.1.6.4.1.Market Estimation, 2013 – 2018

8.2.1.6.4.2.Market Forecast, 2019 – 2027

8.2.1.6.5. Latin America

8.2.1.6.5.1.Market Estimation, 2013 – 2018

8.2.1.6.5.2.Market Forecast, 2019 – 2027

8.2.2. Compressed Oxygen Cylinders

8.2.2.1. Definition

8.2.2.2. Market Penetration, 2018

8.2.2.3. Market Estimation, 2013 – 2018

8.2.2.4. Market Forecast, 2019 – 2027

8.2.2.5. Compound Annual Growth Rate (CAGR)

8.2.2.6. Regional Bifurcation

8.2.2.6.1. North America

8.2.2.6.1.1.Market Estimation, 2013 – 2018

8.2.2.6.1.2.Market Forecast, 2019 – 2027

8.2.2.6.2. Europe

8.2.2.6.2.1.Market Estimation, 2013 – 2018

8.2.2.6.2.2.Market Forecast, 2019 – 2027

8.2.2.6.3. Asia Pacific

8.2.2.6.3.1.Market Estimation, 2013 – 2018

8.2.2.6.3.2.Market Forecast, 2019 – 2027

8.2.2.6.4. Middle East and Africa

8.2.2.6.4.1.Market Estimation, 2013 – 2018

8.2.2.6.4.2.Market Forecast, 2019 – 2027

8.2.2.6.5. Latin America

8.2.2.6.5.1.Market Estimation, 2013 – 2018

8.2.2.6.5.2.Market Forecast, 2019 – 2027

8.2.3. Liquid Oxygen Systems

8.2.3.1. Definition

8.2.3.2. Market Penetration, 2018

8.2.3.3. Market Estimation, 2013 – 2018

8.2.3.4. Market Forecast, 2019 – 2027

8.2.3.5. Compound Annual Growth Rate (CAGR)

8.2.3.6. Regional Bifurcation

8.2.3.6.1. North America

8.2.3.6.1.1.Market Estimation, 2013 – 2018

8.2.3.6.1.2.Market Forecast, 2019 – 2027

8.2.3.6.2. Europe

8.2.3.6.2.1.Market Estimation, 2013 – 2018

8.2.3.6.2.2.Market Forecast, 2019 – 2027

8.2.3.6.3. Asia Pacific

8.2.3.6.3.1.Market Estimation, 2013 – 2018

8.2.3.6.3.2.Market Forecast, 2019 – 2027

8.2.3.6.4. Middle East and Africa

8.2.3.6.4.1.Market Estimation, 2013 – 2018

8.2.3.6.4.2.Market Forecast, 2019 – 2027

8.2.3.6.5. Latin America

8.2.3.6.5.1.Market Estimation, 2013 – 2018

8.2.3.6.5.2.Market Forecast, 2019 – 2027

8.3. Key Segment for Channeling Investments

8.3.1. By Oxygen Source Equipment

9. Global Oxygen Therapy Market Analysis and Forecasts, 2019 – 2027

9.1. Overview

9.2. Global Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

9.2.1. Oxygen Masks

9.2.1.1. Definition

9.2.1.2. Market Penetration, 2018

9.2.1.3. Market Estimation, 2013 – 2018

9.2.1.4. Market Forecast, 2019 – 2027

9.2.1.5. Compound Annual Growth Rate (CAGR)

9.2.1.6. Regional Bifurcation

9.2.1.6.1. North America

9.2.1.6.1.1.Market Estimation, 2013 – 2018

9.2.1.6.1.2.Market Forecast, 2019 – 2027

9.2.1.6.2. Europe

9.2.1.6.2.1.Market Estimation, 2013 – 2018

9.2.1.6.2.2.Market Forecast, 2019 – 2027

9.2.1.6.3. Asia Pacific

9.2.1.6.3.1.Market Estimation, 2013 – 2018

9.2.1.6.3.2.Market Forecast, 2019 – 2027

9.2.1.6.4. Middle East and Africa

9.2.1.6.4.1.Market Estimation, 2013 – 2018

9.2.1.6.4.2.Market Forecast, 2019 – 2027

9.2.1.6.5. Latin America

9.2.1.6.5.1.Market Estimation, 2013 – 2018

9.2.1.6.5.2.Market Forecast, 2019 – 2027

9.2.2. Bag Valve Masks

9.2.2.1. Definition

9.2.2.2. Market Penetration, 2018

9.2.2.3. Market Estimation, 2013 – 2018

9.2.2.4. Market Forecast, 2019 – 2027

9.2.2.5. Compound Annual Growth Rate (CAGR)

9.2.2.6. Regional Bifurcation

9.2.2.6.1. North America

9.2.2.6.1.1.Market Estimation, 2013 – 2018

9.2.2.6.1.2.Market Forecast, 2019 – 2027

9.2.2.6.2. Europe

9.2.2.6.2.1.Market Estimation, 2013 – 2018

9.2.2.6.2.2.Market Forecast, 2019 – 2027

9.2.2.6.3. Asia Pacific

9.2.2.6.3.1.Market Estimation, 2013 – 2018

9.2.2.6.3.2.Market Forecast, 2019 – 2027

9.2.2.6.4. Middle East and Africa

9.2.2.6.4.1.Market Estimation, 2013 – 2018

9.2.2.6.4.2.Market Forecast, 2019 – 2027

9.2.2.6.5. Latin America

9.2.2.6.5.1.Market Estimation, 2013 – 2018

9.2.2.6.5.2.Market Forecast, 2019 – 2027

9.2.3. Nasal Cannulas

9.2.3.1. Definition

9.2.3.2. Market Penetration, 2018

9.2.3.3. Market Estimation, 2013 – 2018

9.2.3.4. Market Forecast, 2019 – 2027

9.2.3.5. Compound Annual Growth Rate (CAGR)

9.2.3.6. Regional Bifurcation

9.2.3.6.1. North America

9.2.3.6.1.1.Market Estimation, 2013 – 2018

9.2.3.6.1.2.Market Forecast, 2019 – 2027

9.2.3.6.2. Europe

9.2.3.6.2.1.Market Estimation, 2013 – 2018

9.2.3.6.2.2.Market Forecast, 2019 – 2027

9.2.3.6.3. Asia Pacific

9.2.3.6.3.1.Market Estimation, 2013 – 2018

9.2.3.6.3.2.Market Forecast, 2019 – 2027

9.2.3.6.4. Middle East and Africa

9.2.3.6.4.1.Market Estimation, 2013 – 2018

9.2.3.6.4.2.Market Forecast, 2019 – 2027

9.2.3.6.5. Latin America

9.2.3.6.5.1.Market Estimation, 2013 – 2018

9.2.3.6.5.2.Market Forecast, 2019 – 2027

9.2.4. Venturi Mask

9.2.4.1. Definition

9.2.4.2. Market Penetration, 2018

9.2.4.3. Market Estimation, 2013 – 2018

9.2.4.4. Market Forecast, 2019 – 2027

9.2.4.5. Compound Annual Growth Rate (CAGR)

9.2.4.6. Regional Bifurcation

9.2.4.6.1. North America

9.2.4.6.1.1.Market Estimation, 2013 – 2018

9.2.4.6.1.2.Market Forecast, 2019 – 2027

9.2.4.6.2. Europe

9.2.4.6.2.1.Market Estimation, 2013 – 2018

9.2.4.6.2.2.Market Forecast, 2019 – 2027

9.2.4.6.3. Asia Pacific

9.2.4.6.3.1.Market Estimation, 2013 – 2018

9.2.4.6.3.2.Market Forecast, 2019 – 2027

9.2.4.6.4. Middle East and Africa

9.2.4.6.4.1.Market Estimation, 2013 – 2018

9.2.4.6.4.2.Market Forecast, 2019 – 2027

9.2.4.6.5. Latin America

9.2.4.6.5.1.Market Estimation, 2013 – 2018

9.2.4.6.5.2.Market Forecast, 2019 – 2027

9.2.5. Others

9.2.5.1. Definition

9.2.5.2. Market Penetration, 2018

9.2.5.3. Market Estimation, 2013 – 2018

9.2.5.4. Market Forecast, 2019 – 2027

9.2.5.5. Compound Annual Growth Rate (CAGR)

9.2.5.6. Regional Bifurcation

9.2.5.6.1. North America

9.2.5.6.1.1.Market Estimation, 2013 – 2018

9.2.5.6.1.2.Market Forecast, 2019 – 2027

9.2.5.6.2. Europe

9.2.5.6.2.1.Market Estimation, 2013 – 2018

9.2.5.6.2.2.Market Forecast, 2019 – 2027

9.2.5.6.3. Asia Pacific

9.2.5.6.3.1.Market Estimation, 2013 – 2018

9.2.5.6.3.2.Market Forecast, 2019 – 2027

9.2.5.6.4. Middle East and Africa

9.2.5.6.4.1.Market Estimation, 2013 – 2018

9.2.5.6.4.2.Market Forecast, 2019 – 2027

9.2.5.6.5. Latin America

9.2.5.6.5.1.Market Estimation, 2013 – 2018

9.2.5.6.5.2.Market Forecast, 2019 – 2027

9.3. Key Segment for Channeling Investments

9.3.1. By Oxygen Delivery Devices

10. Global Oxygen Therapy Market Analysis and Forecasts, 2019 – 2027

10.1. Overview

10.2. Global Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

10.2.1. Hospitals and Clinics

10.2.1.1. Definition

10.2.1.2. Market Penetration, 2018

10.2.1.3. Market Estimation, 2013 – 2018

10.2.1.4. Market Forecast, 2019 – 2027

10.2.1.5. Compound Annual Growth Rate (CAGR)

10.2.1.6. Regional Bifurcation

10.2.1.6.1. North America

10.2.1.6.1.1.Market Estimation, 2013 – 2018

10.2.1.6.1.2.Market Forecast, 2019 – 2027

10.2.1.6.2. Europe

10.2.1.6.2.1.Market Estimation, 2013 – 2018

10.2.1.6.2.2.Market Forecast, 2019 – 2027

10.2.1.6.3. Asia Pacific

10.2.1.6.3.1.Market Estimation, 2013 – 2018

10.2.1.6.3.2.Market Forecast, 2019 – 2027

10.2.1.6.4. Middle East and Africa

10.2.1.6.4.1.Market Estimation, 2013 – 2018

10.2.1.6.4.2.Market Forecast, 2019 – 2027

10.2.1.6.5. Latin America

10.2.1.6.5.1.Market Estimation, 2013 – 2018

10.2.1.6.5.2.Market Forecast, 2019 – 2027

10.2.2. Home Healthcare

10.2.2.1. Definition

10.2.2.2. Market Penetration, 2018

10.2.2.3. Market Estimation, 2013 – 2018

10.2.2.4. Market Forecast, 2019 – 2027

10.2.2.5. Compound Annual Growth Rate (CAGR)

10.2.2.6. Regional Bifurcation

10.2.2.6.1. North America

10.2.2.6.1.1.Market Estimation, 2013 – 2018

10.2.2.6.1.2.Market Forecast, 2019 – 2027

10.2.2.6.2. Europe

10.2.2.6.2.1.Market Estimation, 2013 – 2018

10.2.2.6.2.2.Market Forecast, 2019 – 2027

10.2.2.6.3. Asia Pacific

10.2.2.6.3.1.Market Estimation, 2013 – 2018

10.2.2.6.3.2.Market Forecast, 2019 – 2027

10.2.2.6.4. Middle East and Africa

10.2.2.6.4.1.Market Estimation, 2013 – 2018

10.2.2.6.4.2.Market Forecast, 2019 – 2027

10.2.2.6.5. Latin America

10.2.2.6.5.1.Market Estimation, 2013 – 2018

10.2.2.6.5.2.Market Forecast, 2019 – 2027

10.2.3. Rehabilitation Centers

10.2.3.1. Definition

10.2.3.2. Market Penetration, 2018

10.2.3.3. Market Estimation, 2013 – 2018

10.2.3.4. Market Forecast, 2019 – 2027

10.2.3.5. Compound Annual Growth Rate (CAGR)

10.2.3.6. Regional Bifurcation

10.2.3.6.1. North America

10.2.3.6.1.1.Market Estimation, 2013 – 2018

10.2.3.6.1.2.Market Forecast, 2019 – 2027

10.2.3.6.2. Europe

10.2.3.6.2.1.Market Estimation, 2013 – 2018

10.2.3.6.2.2.Market Forecast, 2019 – 2027

10.2.3.6.3. Asia Pacific

10.2.3.6.3.1.Market Estimation, 2013 – 2018

10.2.3.6.3.2.Market Forecast, 2019 – 2027

10.2.3.6.4. Middle East and Africa

10.2.3.6.4.1.Market Estimation, 2013 – 2018

10.2.3.6.4.2.Market Forecast, 2019 – 2027

10.2.3.6.5. Latin America

10.2.3.6.5.1.Market Estimation, 2013 – 2018

10.2.3.6.5.2.Market Forecast, 2019 – 2027

10.3. Key Segment for Channeling Investments

10.3.1. By End Users

11. Global Oxygen Therapy Market Analysis and Forecasts, 2019 – 2027

11.1. Overview

11.2. Global Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

11.2.1. COPD (Chronic Obstructive Pulmonary Disease)

11.2.1.1. Definition

11.2.1.2. Market Penetration, 2018

11.2.1.3. Market Estimation, 2013 – 2018

11.2.1.4. Market Forecast, 2019 – 2027

11.2.1.5. Compound Annual Growth Rate (CAGR)

11.2.1.6. Regional Bifurcation

11.2.1.6.1. North America

11.2.1.6.1.1.Market Estimation, 2013 – 2018

11.2.1.6.1.2.Market Forecast, 2019 – 2027

11.2.1.6.2. Europe

11.2.1.6.2.1.Market Estimation, 2013 – 2018

11.2.1.6.2.2.Market Forecast, 2019 – 2027

11.2.1.6.3. Asia Pacific

11.2.1.6.3.1.Market Estimation, 2013 – 2018

11.2.1.6.3.2.Market Forecast, 2019 – 2027

11.2.1.6.4. Middle East and Africa

11.2.1.6.4.1.Market Estimation, 2013 – 2018

11.2.1.6.4.2.Market Forecast, 2019 – 2027

11.2.1.6.5. Latin America

11.2.1.6.5.1.Market Estimation, 2013 – 2018

11.2.1.6.5.2.Market Forecast, 2019 – 2027

11.2.2. Asthma

11.2.2.1. Definition

11.2.2.2. Market Penetration, 2018

11.2.2.3. Market Estimation, 2013 – 2018

11.2.2.4. Market Forecast, 2019 – 2027

11.2.2.5. Compound Annual Growth Rate (CAGR)

11.2.2.6. Regional Bifurcation

11.2.2.6.1. North America

11.2.2.6.1.1.Market Estimation, 2013 – 2018

11.2.2.6.1.2.Market Forecast, 2019 – 2027

11.2.2.6.2. Europe

11.2.2.6.2.1.Market Estimation, 2013 – 2018

11.2.2.6.2.2.Market Forecast, 2019 – 2027

11.2.2.6.3. Asia Pacific

11.2.2.6.3.1.Market Estimation, 2013 – 2018

11.2.2.6.3.2.Market Forecast, 2019 – 2027

11.2.2.6.4. Middle East and Africa

11.2.2.6.4.1.Market Estimation, 2013 – 2018

11.2.2.6.4.2.Market Forecast, 2019 – 2027

11.2.2.6.5. Latin America

11.2.2.6.5.1.Market Estimation, 2013 – 2018

11.2.2.6.5.2.Market Forecast, 2019 – 2027

11.2.3. Sleep Apnea

11.2.3.1. Definition

11.2.3.2. Market Penetration, 2018

11.2.3.3. Market Estimation, 2013 – 2018

11.2.3.4. Market Forecast, 2019 – 2027

11.2.3.5. Compound Annual Growth Rate (CAGR)

11.2.3.6. Regional Bifurcation

11.2.3.6.1. North America

11.2.3.6.1.1.Market Estimation, 2013 – 2018

11.2.3.6.1.2.Market Forecast, 2019 – 2027

11.2.3.6.2. Europe

11.2.3.6.2.1.Market Estimation, 2013 – 2018

11.2.3.6.2.2.Market Forecast, 2019 – 2027

11.2.3.6.3. Asia Pacific

11.2.3.6.3.1.Market Estimation, 2013 – 2018

11.2.3.6.3.2.Market Forecast, 2019 – 2027

11.2.3.6.4. Middle East and Africa

11.2.3.6.4.1.Market Estimation, 2013 – 2018

11.2.3.6.4.2.Market Forecast, 2019 – 2027

11.2.3.6.5. Latin America

11.2.3.6.5.1.Market Estimation, 2013 – 2018

11.2.3.6.5.2.Market Forecast, 2019 – 2027

11.2.4. Respiratory Distress Syndrome (RDS)

11.2.4.1. Definition

11.2.4.2. Market Penetration, 2018

11.2.4.3. Market Estimation, 2013 – 2018

11.2.4.4. Market Forecast, 2019 – 2027

11.2.4.5. Compound Annual Growth Rate (CAGR)

11.2.4.6. Regional Bifurcation

11.2.4.6.1. North America

11.2.4.6.1.1.Market Estimation, 2013 – 2018

11.2.4.6.1.2.Market Forecast, 2019 – 2027

11.2.4.6.2. Europe

11.2.4.6.2.1.Market Estimation, 2013 – 2018

11.2.4.6.2.2.Market Forecast, 2019 – 2027

11.2.4.6.3. Asia Pacific

11.2.4.6.3.1.Market Estimation, 2013 – 2018

11.2.4.6.3.2.Market Forecast, 2019 – 2027

11.2.4.6.4. Middle East and Africa

11.2.4.6.4.1.Market Estimation, 2013 – 2018

11.2.4.6.4.2.Market Forecast, 2019 – 2027

11.2.4.6.5. Latin America

11.2.4.6.5.1.Market Estimation, 2013 – 2018

11.2.4.6.5.2.Market Forecast, 2019 – 2027

11.2.5. Cystic Fibrosis Pneumonia

11.2.5.1. Definition

11.2.5.2. Market Penetration, 2018

11.2.5.3. Market Estimation, 2013 – 2018

11.2.5.4. Market Forecast, 2019 – 2027

11.2.5.5. Compound Annual Growth Rate (CAGR)

11.2.5.6. Regional Bifurcation

11.2.5.6.1. North America

11.2.5.6.1.1.Market Estimation, 2013 – 2018

11.2.5.6.1.2.Market Forecast, 2019 – 2027

11.2.5.6.2. Europe

11.2.5.6.2.1.Market Estimation, 2013 – 2018

11.2.5.6.2.2.Market Forecast, 2019 – 2027

11.2.5.6.3. Asia Pacific

11.2.5.6.3.1.Market Estimation, 2013 – 2018

11.2.5.6.3.2.Market Forecast, 2019 – 2027

11.2.5.6.4. Middle East and Africa

11.2.5.6.4.1.Market Estimation, 2013 – 2018

11.2.5.6.4.2.Market Forecast, 2019 – 2027

11.2.5.6.5. Latin America

11.2.5.6.5.1.Market Estimation, 2013 – 2018

11.2.5.6.5.2.Market Forecast, 2019 – 2027

11.2.6. Others

11.2.6.1. Definition

11.2.6.2. Market Penetration, 2018

11.2.6.3. Market Estimation, 2013 – 2018

11.2.6.4. Market Forecast, 2019 – 2027

11.2.6.5. Compound Annual Growth Rate (CAGR)

11.2.6.6. Regional Bifurcation

11.2.6.6.1. North America

11.2.6.6.1.1.Market Estimation, 2013 – 2018

11.2.6.6.1.2.Market Forecast, 2019 – 2027

11.2.6.6.2. Europe

11.2.6.6.2.1.Market Estimation, 2013 – 2018

11.2.6.6.2.2.Market Forecast, 2019 – 2027

11.2.6.6.3. Asia Pacific

11.2.6.6.3.1.Market Estimation, 2013 – 2018

11.2.6.6.3.2.Market Forecast, 2019 – 2027

11.2.6.6.4. Middle East and Africa

11.2.6.6.4.1.Market Estimation, 2013 – 2018

11.2.6.6.4.2.Market Forecast, 2019 – 2027

11.2.6.6.5. Latin America

11.2.6.6.5.1.Market Estimation, 2013 – 2018

11.2.6.6.5.2.Market Forecast, 2019 – 2027

11.3. Key Segment for Channeling Investments

11.3.1. By Application

12. North America Oxygen Therapy Market Analysis and Forecasts, 2019 - 2027

12.1. Overview

12.1.1. North America Oxygen Therapy Market Revenue (US$ Mn)

12.2. North America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

12.2.1. Oxygen Concentrators

12.2.2. Compressed Oxygen Cylinders

12.2.3. Liquid Oxygen Systems

12.3. North America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

12.3.1. Oxygen Masks

12.3.2. Bag Valve Masks

12.3.3. Nasal Cannulas

12.3.4. Venturi Mask

12.3.5. Others

12.4. North America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

12.4.1. Hospitals and Clinics

12.4.2. Home Healthcare

12.4.3. Rehabilitation Centers

12.5. North America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

12.5.1. COPD (Chronic Obstructive Pulmonary Disease)

12.5.2. Asthma

12.5.3. Sleep Apnea

12.5.4. Respiratory Distress Syndrome (RDS)

12.5.5. Cystic Fibrosis Pneumonia

12.5.6. Others

12.6. North America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Country

12.6.1. U.S

12.6.1.1. U.S Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

12.6.1.1.1. Oxygen Concentrators

12.6.1.1.2. Compressed Oxygen Cylinders

12.6.1.1.3. Liquid Oxygen Systems

12.6.1.2. U.S Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

12.6.1.2.1. Oxygen Masks

12.6.1.2.2. Bag Valve Masks

12.6.1.2.3. Nasal Cannulas

12.6.1.2.4. Venturi Mask

12.6.1.2.5. Others

12.6.1.3. U.S Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

12.6.1.3.1. Hospitals and Clinics

12.6.1.3.2. Home Healthcare

12.6.1.3.3. Rehabilitation Centers

12.6.1.4. U.S Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

12.6.1.4.1. COPD (Chronic Obstructive Pulmonary Disease)

12.6.1.4.2. Asthma

12.6.1.4.3. Sleep Apnea

12.6.1.4.4. Respiratory Distress Syndrome (RDS)

12.6.1.4.5. Cystic Fibrosis Pneumonia

12.6.1.4.6. Others

12.6.2. Canada

12.6.2.1. Canada Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

12.6.2.1.1. Oxygen Concentrators

12.6.2.1.2. Compressed Oxygen Cylinders

12.6.2.1.3. Liquid Oxygen Systems

12.6.2.2. Canada Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

12.6.2.2.1. Oxygen Masks

12.6.2.2.2. Bag Valve Masks

12.6.2.2.3. Nasal Cannulas

12.6.2.2.4. Venturi Mask

12.6.2.2.5. Others

12.6.2.3. Canada Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

12.6.2.3.1. Hospitals and Clinics

12.6.2.3.2. Home Healthcare

12.6.2.3.3. Rehabilitation Centers

12.6.2.4. Canada Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

12.6.2.4.1. COPD (Chronic Obstructive Pulmonary Disease)

12.6.2.4.2. Asthma

12.6.2.4.3. Sleep Apnea

12.6.2.4.4. Respiratory Distress Syndrome (RDS)

12.6.2.4.5. Cystic Fibrosis Pneumonia

12.6.2.4.6. Others

12.6.3. Mexico

12.6.3.1. Mexico Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

12.6.3.1.1. Oxygen Concentrators

12.6.3.1.2. Compressed Oxygen Cylinders

12.6.3.1.3. Liquid Oxygen Systems

12.6.3.2. Mexico Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

12.6.3.2.1. Oxygen Masks

12.6.3.2.2. Bag Valve Masks

12.6.3.2.3. Nasal Cannulas

12.6.3.2.4. Venturi Mask

12.6.3.2.5. Others

12.6.3.3. Mexico Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

12.6.3.3.1. Hospitals and Clinics

12.6.3.3.2. Home Healthcare

12.6.3.3.3. Rehabilitation Centers

12.6.3.4. Mexico Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

12.6.3.4.1. COPD (Chronic Obstructive Pulmonary Disease)

12.6.3.4.2. Asthma

12.6.3.4.3. Sleep Apnea

12.6.3.4.4. Respiratory Distress Syndrome (RDS)

12.6.3.4.5. Cystic Fibrosis Pneumonia

12.6.3.4.6. Others

12.6.4. Rest of North America

12.6.4.1. Rest of North America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

12.6.4.1.1. Oxygen Concentrators

12.6.4.1.2. Compressed Oxygen Cylinders

12.6.4.1.3. Liquid Oxygen Systems

12.6.4.2. Rest of North America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

12.6.4.2.1. Oxygen Masks

12.6.4.2.2. Bag Valve Masks

12.6.4.2.3. Nasal Cannulas

12.6.4.2.4. Venturi Mask

12.6.4.2.5. Others

12.6.4.3. Rest of North America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

12.6.4.3.1. Hospitals and Clinics

12.6.4.3.2. Home Healthcare

12.6.4.3.3. Rehabilitation Centers

12.6.4.4. Rest of North America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

12.6.4.4.1. COPD (Chronic Obstructive Pulmonary Disease)

12.6.4.4.2. Asthma

12.6.4.4.3. Sleep Apnea

12.6.4.4.4. Respiratory Distress Syndrome (RDS)

12.6.4.4.5. Cystic Fibrosis Pneumonia

12.6.4.4.6. Others

12.7. Key Segment for Channeling Investments

12.7.1. By Country

12.7.2. By Oxygen Source Equipment

12.7.3. By Oxygen Delivery Devices

12.7.4. By End Users

12.7.5. By Application

13. Europe Oxygen Therapy Market Analysis and Forecasts, 2019 - 2027

13.1. Overview

13.1.1. Europe Oxygen Therapy Market Revenue (US$ Mn)

13.2. Europe Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

13.2.1. Oxygen Concentrators

13.2.2. Compressed Oxygen Cylinders

13.2.3. Liquid Oxygen Systems

13.3. Europe Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

13.3.1. Oxygen Masks

13.3.2. Bag Valve Masks

13.3.3. Nasal Cannulas

13.3.4. Venturi Mask

13.3.5. Others

13.4. Europe Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

13.4.1. Hospitals and Clinics

13.4.2. Home Healthcare

13.4.3. Rehabilitation Centers

13.5. Europe Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

13.5.1. COPD (Chronic Obstructive Pulmonary Disease)

13.5.2. Asthma

13.5.3. Sleep Apnea

13.5.4. Respiratory Distress Syndrome (RDS)

13.5.5. Cystic Fibrosis Pneumonia

13.5.6. Others

13.6. Europe Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Country

13.6.1. France

13.6.1.1. France Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

13.6.1.1.1. Oxygen Concentrators

13.6.1.1.2. Compressed Oxygen Cylinders

13.6.1.1.3. Liquid Oxygen Systems

13.6.1.2. France Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

13.6.1.2.1. Oxygen Masks

13.6.1.2.2. Bag Valve Masks

13.6.1.2.3. Nasal Cannulas

13.6.1.2.4. Venturi Mask

13.6.1.2.5. Others

13.6.1.3. France Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.1.3.1. Hospitals and Clinics

13.6.1.3.2. Home Healthcare

13.6.1.3.3. Rehabilitation Centers

13.6.1.4. France Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

13.6.1.4.1. COPD (Chronic Obstructive Pulmonary Disease)

13.6.1.4.2. Asthma

13.6.1.4.3. Sleep Apnea

13.6.1.4.4. Respiratory Distress Syndrome (RDS)

13.6.1.4.5. Cystic Fibrosis Pneumonia

13.6.1.4.6. Others

13.6.2. The UK

13.6.2.1. The UK Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

13.6.2.1.1. Oxygen Concentrators

13.6.2.1.2. Compressed Oxygen Cylinders

13.6.2.1.3. Liquid Oxygen Systems

13.6.2.2. The UK Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

13.6.2.2.1. Oxygen Masks

13.6.2.2.2. Bag Valve Masks

13.6.2.2.3. Nasal Cannulas

13.6.2.2.4. Venturi Mask

13.6.2.2.5. Others

13.6.2.3. The UK Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.2.3.1. Hospitals and Clinics

13.6.2.3.2. Home Healthcare

13.6.2.3.3. Rehabilitation Centers

13.6.2.4. The UK Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

13.6.2.4.1. COPD (Chronic Obstructive Pulmonary Disease)

13.6.2.4.2. Asthma

13.6.2.4.3. Sleep Apnea

13.6.2.4.4. Respiratory Distress Syndrome (RDS)

13.6.2.4.5. Cystic Fibrosis Pneumonia

13.6.2.4.6. Others

13.6.3. Spain

13.6.3.1. Spain Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

13.6.3.1.1. Oxygen Concentrators

13.6.3.1.2. Compressed Oxygen Cylinders

13.6.3.1.3. Liquid Oxygen Systems

13.6.3.2. Spain Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

13.6.3.2.1. Oxygen Masks

13.6.3.2.2. Bag Valve Masks

13.6.3.2.3. Nasal Cannulas

13.6.3.2.4. Venturi Mask

13.6.3.2.5. Others

13.6.3.3. Spain Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.3.3.1. Hospitals and Clinics

13.6.3.3.2. Home Healthcare

13.6.3.3.3. Rehabilitation Centers

13.6.3.4. Spain Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

13.6.3.4.1. COPD (Chronic Obstructive Pulmonary Disease)

13.6.3.4.2. Asthma

13.6.3.4.3. Sleep Apnea

13.6.3.4.4. Respiratory Distress Syndrome (RDS)

13.6.3.4.5. Cystic Fibrosis Pneumonia

13.6.3.4.6. Others

13.6.4. Germany

13.6.4.1. Germany Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

13.6.4.1.1. Oxygen Concentrators

13.6.4.1.2. Compressed Oxygen Cylinders

13.6.4.1.3. Liquid Oxygen Systems

13.6.4.2. Germany Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

13.6.4.2.1. Oxygen Masks

13.6.4.2.2. Bag Valve Masks

13.6.4.2.3. Nasal Cannulas

13.6.4.2.4. Venturi Mask

13.6.4.2.5. Others

13.6.4.3. Germany Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.4.3.1. Hospitals and Clinics

13.6.4.3.2. Home Healthcare

13.6.4.3.3. Rehabilitation Centers

13.6.4.4. Germany Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

13.6.4.4.1. COPD (Chronic Obstructive Pulmonary Disease)

13.6.4.4.2. Asthma

13.6.4.4.3. Sleep Apnea

13.6.4.4.4. Respiratory Distress Syndrome (RDS)

13.6.4.4.5. Cystic Fibrosis Pneumonia

13.6.4.4.6. Others

13.6.5. Italy

13.6.5.1. Italy Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

13.6.5.1.1. Oxygen Concentrators

13.6.5.1.2. Compressed Oxygen Cylinders

13.6.5.1.3. Liquid Oxygen Systems

13.6.5.2. Italy Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

13.6.5.2.1. Oxygen Masks

13.6.5.2.2. Bag Valve Masks

13.6.5.2.3. Nasal Cannulas

13.6.5.2.4. Venturi Mask

13.6.5.2.5. Others

13.6.5.3. Italy Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.5.3.1. Hospitals and Clinics

13.6.5.3.2. Home Healthcare

13.6.5.3.3. Rehabilitation Centers

13.6.5.4. Italy Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

13.6.5.4.1. COPD (Chronic Obstructive Pulmonary Disease)

13.6.5.4.2. Asthma

13.6.5.4.3. Sleep Apnea

13.6.5.4.4. Respiratory Distress Syndrome (RDS)

13.6.5.4.5. Cystic Fibrosis Pneumonia

13.6.5.4.6. Others

13.6.6. Nordic Countries

13.6.6.1. Nordic Countries Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

13.6.6.1.1. Oxygen Concentrators

13.6.6.1.2. Compressed Oxygen Cylinders

13.6.6.1.3. Liquid Oxygen Systems

13.6.6.2. Nordic Countries Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

13.6.6.2.1. Oxygen Masks

13.6.6.2.2. Bag Valve Masks

13.6.6.2.3. Nasal Cannulas

13.6.6.2.4. Venturi Mask

13.6.6.2.5. Others

13.6.6.3. Nordic Countries Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.6.3.1. Hospitals and Clinics

13.6.6.3.2. Home Healthcare

13.6.6.3.3. Rehabilitation Centers

13.6.6.4. Nordic Countries Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

13.6.6.4.1. COPD (Chronic Obstructive Pulmonary Disease)

13.6.6.4.2. Asthma

13.6.6.4.3. Sleep Apnea

13.6.6.4.4. Respiratory Distress Syndrome (RDS)

13.6.6.4.5. Cystic Fibrosis Pneumonia

13.6.6.4.6. Others

13.6.6.5. Nordic Countries Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Country

13.6.6.5.1. Denmark

13.6.6.5.2. Finland

13.6.6.5.3. Iceland

13.6.6.5.4. Sweden

13.6.6.5.5. Norway

13.6.7. Benelux Union

13.6.7.1. Benelux Union Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

13.6.7.1.1. Oxygen Concentrators

13.6.7.1.2. Compressed Oxygen Cylinders

13.6.7.1.3. Liquid Oxygen Systems

13.6.7.2. Benelux Union Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

13.6.7.2.1. Oxygen Masks

13.6.7.2.2. Bag Valve Masks

13.6.7.2.3. Nasal Cannulas

13.6.7.2.4. Venturi Mask

13.6.7.2.5. Others

13.6.7.3. Benelux Union Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.7.3.1. Hospitals and Clinics

13.6.7.3.2. Home Healthcare

13.6.7.3.3. Rehabilitation Centers

13.6.7.4. Benelux Union Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

13.6.7.4.1. COPD (Chronic Obstructive Pulmonary Disease)

13.6.7.4.2. Asthma

13.6.7.4.3. Sleep Apnea

13.6.7.4.4. Respiratory Distress Syndrome (RDS)

13.6.7.4.5. Cystic Fibrosis Pneumonia

13.6.7.4.6. Others

13.6.7.5. Benelux Union Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Country

13.6.7.5.1. Belgium

13.6.7.5.2. The Netherlands

13.6.7.5.3. Luxembourg

13.6.8. Rest of Europe

13.6.8.1. Rest of Europe Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

13.6.8.1.1. Oxygen Concentrators

13.6.8.1.2. Compressed Oxygen Cylinders

13.6.8.1.3. Liquid Oxygen Systems

13.6.8.2. Rest of Europe Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

13.6.8.2.1. Oxygen Masks

13.6.8.2.2. Bag Valve Masks

13.6.8.2.3. Nasal Cannulas

13.6.8.2.4. Venturi Mask

13.6.8.2.5. Others

13.6.8.3. Rest of Europe Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.8.3.1. Hospitals and Clinics

13.6.8.3.2. Home Healthcare

13.6.8.3.3. Rehabilitation Centers

13.6.8.4. Rest of Europe Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

13.6.8.4.1. COPD (Chronic Obstructive Pulmonary Disease)

13.6.8.4.2. Asthma

13.6.8.4.3. Sleep Apnea

13.6.8.4.4. Respiratory Distress Syndrome (RDS)

13.6.8.4.5. Cystic Fibrosis Pneumonia

13.6.8.4.6. Others

13.7. Key Segment for Channeling Investments

13.7.1. By Country

13.7.2. By Oxygen Source Equipment

13.7.3. By Oxygen Delivery Devices

13.7.4. By End Users

13.7.5. By Application

14. Asia Pacific Oxygen Therapy Market Analysis and Forecasts, 2019 - 2027

14.1. Overview

14.1.1. Asia Pacific Oxygen Therapy Market Revenue (US$ Mn)

14.2. Asia Pacific Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

14.2.1. Oxygen Concentrators

14.2.2. Compressed Oxygen Cylinders

14.2.3. Liquid Oxygen Systems

14.3. Asia Pacific Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

14.3.1. Oxygen Masks

14.3.2. Bag Valve Masks

14.3.3. Nasal Cannulas

14.3.4. Venturi Mask

14.3.5. Others

14.4. Asia Pacific Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

14.4.1. Hospitals and Clinics

14.4.2. Home Healthcare

14.4.3. Rehabilitation Centers

14.5. Asia Pacific Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

14.5.1. COPD (Chronic Obstructive Pulmonary Disease)

14.5.2. Asthma

14.5.3. Sleep Apnea

14.5.4. Respiratory Distress Syndrome (RDS)

14.5.5. Cystic Fibrosis Pneumonia

14.5.6. Others

14.6. Asia Pacific Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Country

14.6.1. China

14.6.1.1. China Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

14.6.1.1.1. Oxygen Concentrators

14.6.1.1.2. Compressed Oxygen Cylinders

14.6.1.1.3. Liquid Oxygen Systems

14.6.1.2. China Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

14.6.1.2.1. Oxygen Masks

14.6.1.2.2. Bag Valve Masks

14.6.1.2.3. Nasal Cannulas

14.6.1.2.4. Venturi Mask

14.6.1.2.5. Others

14.6.1.3. China Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.1.3.1. Hospitals and Clinics

14.6.1.3.2. Home Healthcare

14.6.1.3.3. Rehabilitation Centers

14.6.1.4. China Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

14.6.1.4.1. COPD (Chronic Obstructive Pulmonary Disease)

14.6.1.4.2. Asthma

14.6.1.4.3. Sleep Apnea

14.6.1.4.4. Respiratory Distress Syndrome (RDS)

14.6.1.4.5. Cystic Fibrosis Pneumonia

14.6.1.4.6. Others

14.6.2. Japan

14.6.2.1. Japan Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

14.6.2.1.1. Oxygen Concentrators

14.6.2.1.2. Compressed Oxygen Cylinders

14.6.2.1.3. Liquid Oxygen Systems

14.6.2.2. Japan Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

14.6.2.2.1. Oxygen Masks

14.6.2.2.2. Bag Valve Masks

14.6.2.2.3. Nasal Cannulas

14.6.2.2.4. Venturi Mask

14.6.2.2.5. Others

14.6.2.3. Japan Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.2.3.1. Hospitals and Clinics

14.6.2.3.2. Home Healthcare

14.6.2.3.3. Rehabilitation Centers

14.6.2.4. Japan Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

14.6.2.4.1. COPD (Chronic Obstructive Pulmonary Disease)

14.6.2.4.2. Asthma

14.6.2.4.3. Sleep Apnea

14.6.2.4.4. Respiratory Distress Syndrome (RDS)

14.6.2.4.5. Cystic Fibrosis Pneumonia

14.6.2.4.6. Others

14.6.3. India

14.6.3.1. India Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

14.6.3.1.1. Oxygen Concentrators

14.6.3.1.2. Compressed Oxygen Cylinders

14.6.3.1.3. Liquid Oxygen Systems

14.6.3.2. India Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

14.6.3.2.1. Oxygen Masks

14.6.3.2.2. Bag Valve Masks

14.6.3.2.3. Nasal Cannulas

14.6.3.2.4. Venturi Mask

14.6.3.2.5. Others

14.6.3.3. India Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.3.3.1. Hospitals and Clinics

14.6.3.3.2. Home Healthcare

14.6.3.3.3. Rehabilitation Centers

14.6.3.4. India Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

14.6.3.4.1. COPD (Chronic Obstructive Pulmonary Disease)

14.6.3.4.2. Asthma

14.6.3.4.3. Sleep Apnea

14.6.3.4.4. Respiratory Distress Syndrome (RDS)

14.6.3.4.5. Cystic Fibrosis Pneumonia

14.6.3.4.6. Others

14.6.4. New Zealand

14.6.4.1. New Zealand Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

14.6.4.1.1. Oxygen Concentrators

14.6.4.1.2. Compressed Oxygen Cylinders

14.6.4.1.3. Liquid Oxygen Systems

14.6.4.2. New Zealand Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

14.6.4.2.1. Oxygen Masks

14.6.4.2.2. Bag Valve Masks

14.6.4.2.3. Nasal Cannulas

14.6.4.2.4. Venturi Mask

14.6.4.2.5. Others

14.6.4.3. New Zealand Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.4.3.1. Hospitals and Clinics

14.6.4.3.2. Home Healthcare

14.6.4.3.3. Rehabilitation Centers

14.6.4.4. New Zealand Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

14.6.4.4.1. COPD (Chronic Obstructive Pulmonary Disease)

14.6.4.4.2. Asthma

14.6.4.4.3. Sleep Apnea

14.6.4.4.4. Respiratory Distress Syndrome (RDS)

14.6.4.4.5. Cystic Fibrosis Pneumonia

14.6.4.4.6. Others

14.6.5. Australia

14.6.5.1. Australia Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

14.6.5.1.1. Oxygen Concentrators

14.6.5.1.2. Compressed Oxygen Cylinders

14.6.5.1.3. Liquid Oxygen Systems

14.6.5.2. Australia Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

14.6.5.2.1. Oxygen Masks

14.6.5.2.2. Bag Valve Masks

14.6.5.2.3. Nasal Cannulas

14.6.5.2.4. Venturi Mask

14.6.5.2.5. Others

14.6.5.3. Australia Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.5.3.1. Hospitals and Clinics

14.6.5.3.2. Home Healthcare

14.6.5.3.3. Rehabilitation Centers

14.6.5.4. Australia Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

14.6.5.4.1. COPD (Chronic Obstructive Pulmonary Disease)

14.6.5.4.2. Asthma

14.6.5.4.3. Sleep Apnea

14.6.5.4.4. Respiratory Distress Syndrome (RDS)

14.6.5.4.5. Cystic Fibrosis Pneumonia

14.6.5.4.6. Others

14.6.6. South Korea

14.6.6.1. South Korea Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

14.6.6.1.1. Oxygen Concentrators

14.6.6.1.2. Compressed Oxygen Cylinders

14.6.6.1.3. Liquid Oxygen Systems

14.6.6.2. South Korea Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

14.6.6.2.1. Oxygen Masks

14.6.6.2.2. Bag Valve Masks

14.6.6.2.3. Nasal Cannulas

14.6.6.2.4. Venturi Mask

14.6.6.2.5. Others

14.6.6.3. South Korea Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.6.3.1. Hospitals and Clinics

14.6.6.3.2. Home Healthcare

14.6.6.3.3. Rehabilitation Centers

14.6.6.4. South Korea Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

14.6.6.4.1. COPD (Chronic Obstructive Pulmonary Disease)

14.6.6.4.2. Asthma

14.6.6.4.3. Sleep Apnea

14.6.6.4.4. Respiratory Distress Syndrome (RDS)

14.6.6.4.5. Cystic Fibrosis Pneumonia

14.6.6.4.6. Others

14.6.7. Southeast Asia

14.6.7.1. Southeast Asia Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

14.6.7.1.1. Oxygen Concentrators

14.6.7.1.2. Compressed Oxygen Cylinders

14.6.7.1.3. Liquid Oxygen Systems

14.6.7.2. Southeast Asia Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

14.6.7.2.1. Oxygen Masks

14.6.7.2.2. Bag Valve Masks

14.6.7.2.3. Nasal Cannulas

14.6.7.2.4. Venturi Mask

14.6.7.2.5. Others

14.6.7.3. Southeast Asia Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.7.3.1. Hospitals and Clinics

14.6.7.3.2. Home Healthcare

14.6.7.3.3. Rehabilitation Centers

14.6.7.4. Southeast Asia Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

14.6.7.4.1. COPD (Chronic Obstructive Pulmonary Disease)

14.6.7.4.2. Asthma

14.6.7.4.3. Sleep Apnea

14.6.7.4.4. Respiratory Distress Syndrome (RDS)

14.6.7.4.5. Cystic Fibrosis Pneumonia

14.6.7.4.6. Others

14.6.7.5. Southeast Asia Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Country

14.6.7.5.1. Indonesia

14.6.7.5.2. Thailand

14.6.7.5.3. Malaysia

14.6.7.5.4. Singapore

14.6.7.5.5. Rest of Southeast Asia

14.6.8. Rest of Asia Pacific

14.6.8.1. Rest of Asia Pacific Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

14.6.8.1.1. Oxygen Concentrators

14.6.8.1.2. Compressed Oxygen Cylinders

14.6.8.1.3. Liquid Oxygen Systems

14.6.8.2. Rest of Asia Pacific Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

14.6.8.2.1. Oxygen Masks

14.6.8.2.2. Bag Valve Masks

14.6.8.2.3. Nasal Cannulas

14.6.8.2.4. Venturi Mask

14.6.8.2.5. Others

14.6.8.3. Rest of Asia Pacific Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.8.3.1. Hospitals and Clinics

14.6.8.3.2. Home Healthcare

14.6.8.3.3. Rehabilitation Centers

14.6.8.4. Rest of Asia Pacific Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

14.6.8.4.1. COPD (Chronic Obstructive Pulmonary Disease)

14.6.8.4.2. Asthma

14.6.8.4.3. Sleep Apnea

14.6.8.4.4. Respiratory Distress Syndrome (RDS)

14.6.8.4.5. Cystic Fibrosis Pneumonia

14.6.8.4.6. Others

14.7. Key Segment for Channeling Investments

14.7.1. By Country

14.7.2. By Oxygen Source Equipment

14.7.3. By Oxygen Delivery Devices

14.7.4. By End Users

14.7.5. By Application

15. Middle East and Africa Oxygen Therapy Market Analysis and Forecasts, 2019 - 2027

15.1. Overview

15.1.1. Middle East and Africa Oxygen Therapy Market Revenue (US$ Mn)

15.2. Middle East and Africa Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

15.2.1. Oxygen Concentrators

15.2.2. Compressed Oxygen Cylinders

15.2.3. Liquid Oxygen Systems

15.3. Middle East and Africa Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

15.3.1. Oxygen Masks

15.3.2. Bag Valve Masks

15.3.3. Nasal Cannulas

15.3.4. Venturi Mask

15.3.5. Others

15.4. Middle East and Africa Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

15.4.1. Hospitals and Clinics

15.4.2. Home Healthcare

15.4.3. Rehabilitation Centers

15.5. Middle East and Africa Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

15.5.1. COPD (Chronic Obstructive Pulmonary Disease)

15.5.2. Asthma

15.5.3. Sleep Apnea

15.5.4. Respiratory Distress Syndrome (RDS)

15.5.5. Cystic Fibrosis Pneumonia

15.5.6. Others

15.6. Middle East and Africa Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Country

15.6.1. Saudi Arabia

15.6.1.1. Saudi Arabia Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

15.6.1.1.1. Oxygen Concentrators

15.6.1.1.2. Compressed Oxygen Cylinders

15.6.1.1.3. Liquid Oxygen Systems

15.6.1.2. Saudi Arabia Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

15.6.1.2.1. Oxygen Masks

15.6.1.2.2. Bag Valve Masks

15.6.1.2.3. Nasal Cannulas

15.6.1.2.4. Venturi Mask

15.6.1.2.5. Others

15.6.1.3. Saudi Arabia Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

15.6.1.3.1. Hospitals and Clinics

15.6.1.3.2. Home Healthcare

15.6.1.3.3. Rehabilitation Centers

15.6.1.4. Saudi Arabia Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

15.6.1.4.1. COPD (Chronic Obstructive Pulmonary Disease)

15.6.1.4.2. Asthma

15.6.1.4.3. Sleep Apnea

15.6.1.4.4. Respiratory Distress Syndrome (RDS)

15.6.1.4.5. Cystic Fibrosis Pneumonia

15.6.1.4.6. Others

15.6.2. UAE

15.6.2.1. UAE Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

15.6.2.1.1. Oxygen Concentrators

15.6.2.1.2. Compressed Oxygen Cylinders

15.6.2.1.3. Liquid Oxygen Systems

15.6.2.2. UAE Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

15.6.2.2.1. Oxygen Masks

15.6.2.2.2. Bag Valve Masks

15.6.2.2.3. Nasal Cannulas

15.6.2.2.4. Venturi Mask

15.6.2.2.5. Others

15.6.2.3. UAE Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

15.6.2.3.1. Hospitals and Clinics

15.6.2.3.2. Home Healthcare

15.6.2.3.3. Rehabilitation Centers

15.6.2.4. UAE Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

15.6.2.4.1. COPD (Chronic Obstructive Pulmonary Disease)

15.6.2.4.2. Asthma

15.6.2.4.3. Sleep Apnea

15.6.2.4.4. Respiratory Distress Syndrome (RDS)

15.6.2.4.5. Cystic Fibrosis Pneumonia

15.6.2.4.6. Others

15.6.3. Egypt

15.6.3.1. Egypt Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

15.6.3.1.1. Oxygen Concentrators

15.6.3.1.2. Compressed Oxygen Cylinders

15.6.3.1.3. Liquid Oxygen Systems

15.6.3.2. Egypt Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

15.6.3.2.1. Oxygen Masks

15.6.3.2.2. Bag Valve Masks

15.6.3.2.3. Nasal Cannulas

15.6.3.2.4. Venturi Mask

15.6.3.2.5. Others

15.6.3.3. Egypt Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

15.6.3.3.1. Hospitals and Clinics

15.6.3.3.2. Home Healthcare

15.6.3.3.3. Rehabilitation Centers

15.6.3.4. Egypt Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

15.6.3.4.1. COPD (Chronic Obstructive Pulmonary Disease)

15.6.3.4.2. Asthma

15.6.3.4.3. Sleep Apnea

15.6.3.4.4. Respiratory Distress Syndrome (RDS)

15.6.3.4.5. Cystic Fibrosis Pneumonia

15.6.3.4.6. Others

15.6.4. Kuwait

15.6.4.1. Kuwait Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

15.6.4.1.1. Oxygen Concentrators

15.6.4.1.2. Compressed Oxygen Cylinders

15.6.4.1.3. Liquid Oxygen Systems

15.6.4.2. Kuwait Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

15.6.4.2.1. Oxygen Masks

15.6.4.2.2. Bag Valve Masks

15.6.4.2.3. Nasal Cannulas

15.6.4.2.4. Venturi Mask

15.6.4.2.5. Others

15.6.4.3. Kuwait Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

15.6.4.3.1. Hospitals and Clinics

15.6.4.3.2. Home Healthcare

15.6.4.3.3. Rehabilitation Centers

15.6.4.4. Kuwait Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

15.6.4.4.1. COPD (Chronic Obstructive Pulmonary Disease)

15.6.4.4.2. Asthma

15.6.4.4.3. Sleep Apnea

15.6.4.4.4. Respiratory Distress Syndrome (RDS)

15.6.4.4.5. Cystic Fibrosis Pneumonia

15.6.4.4.6. Others

15.6.5. South Africa

15.6.5.1. South Africa Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

15.6.5.1.1. Oxygen Concentrators

15.6.5.1.2. Compressed Oxygen Cylinders

15.6.5.1.3. Liquid Oxygen Systems

15.6.5.2. South Africa Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

15.6.5.2.1. Oxygen Masks

15.6.5.2.2. Bag Valve Masks

15.6.5.2.3. Nasal Cannulas

15.6.5.2.4. Venturi Mask

15.6.5.2.5. Others

15.6.5.3. South Africa Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

15.6.5.3.1. Hospitals and Clinics

15.6.5.3.2. Home Healthcare

15.6.5.3.3. Rehabilitation Centers

15.6.5.4. South Africa Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

15.6.5.4.1. COPD (Chronic Obstructive Pulmonary Disease)

15.6.5.4.2. Asthma

15.6.5.4.3. Sleep Apnea

15.6.5.4.4. Respiratory Distress Syndrome (RDS)

15.6.5.4.5. Cystic Fibrosis Pneumonia

15.6.5.4.6. Others

15.6.6. Rest of Middle East & Africa

15.6.6.1. Rest of Middle East & Africa Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

15.6.6.1.1. Oxygen Concentrators

15.6.6.1.2. Compressed Oxygen Cylinders

15.6.6.1.3. Liquid Oxygen Systems

15.6.6.2. Rest of Middle East & Africa Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

15.6.6.2.1. Oxygen Masks

15.6.6.2.2. Bag Valve Masks

15.6.6.2.3. Nasal Cannulas

15.6.6.2.4. Venturi Mask

15.6.6.2.5. Others

15.6.6.3. Rest of Middle East & Africa Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

15.6.6.3.1. Hospitals and Clinics

15.6.6.3.2. Home Healthcare

15.6.6.3.3. Rehabilitation Centers

15.6.6.4. Rest of Middle East & Africa Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

15.6.6.4.1. COPD (Chronic Obstructive Pulmonary Disease)

15.6.6.4.2. Asthma

15.6.6.4.3. Sleep Apnea

15.6.6.4.4. Respiratory Distress Syndrome (RDS)

15.6.6.4.5. Cystic Fibrosis Pneumonia

15.6.6.4.6. Others

15.7. Key Segment for Channeling Investments

15.7.1. By Country

15.7.2. By Oxygen Source Equipment

15.7.3. By Oxygen Delivery Devices

15.7.4. By End Users

15.7.5. By Application

16. Latin America Oxygen Therapy Market Analysis and Forecasts, 2019 - 2027

16.1. Overview

16.1.1. Latin America Oxygen Therapy Market Revenue (US$ Mn)

16.2. Latin America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

16.2.1. Oxygen Concentrators

16.2.2. Compressed Oxygen Cylinders

16.2.3. Liquid Oxygen Systems

16.3. Latin America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

16.3.1. Oxygen Masks

16.3.2. Bag Valve Masks

16.3.3. Nasal Cannulas

16.3.4. Venturi Mask

16.3.5. Others

16.4. Latin America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

16.4.1. Hospitals and Clinics

16.4.2. Home Healthcare

16.4.3. Rehabilitation Centers

16.5. Latin America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

16.5.1. COPD (Chronic Obstructive Pulmonary Disease)

16.5.2. Asthma

16.5.3. Sleep Apnea

16.5.4. Respiratory Distress Syndrome (RDS)

16.5.5. Cystic Fibrosis Pneumonia

16.5.6. Others

16.6. Latin America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Country

16.6.1. Brazil

16.6.1.1. Brazil Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

16.6.1.1.1. Oxygen Concentrators

16.6.1.1.2. Compressed Oxygen Cylinders

16.6.1.1.3. Liquid Oxygen Systems

16.6.1.2. Brazil Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

16.6.1.2.1. Oxygen Masks

16.6.1.2.2. Bag Valve Masks

16.6.1.2.3. Nasal Cannulas

16.6.1.2.4. Venturi Mask

16.6.1.2.5. Others

16.6.1.3. Brazil Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

16.6.1.3.1. Hospitals and Clinics

16.6.1.3.2. Home Healthcare

16.6.1.3.3. Rehabilitation Centers

16.6.1.4. Brazil Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

16.6.1.4.1. COPD (Chronic Obstructive Pulmonary Disease)

16.6.1.4.2. Asthma

16.6.1.4.3. Sleep Apnea

16.6.1.4.4. Respiratory Distress Syndrome (RDS)

16.6.1.4.5. Cystic Fibrosis Pneumonia

16.6.1.4.6. Others

16.6.2. Argentina

16.6.2.1. Argentina Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

16.6.2.1.1. Oxygen Concentrators

16.6.2.1.2. Compressed Oxygen Cylinders

16.6.2.1.3. Liquid Oxygen Systems

16.6.2.2. Argentina Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

16.6.2.2.1. Oxygen Masks

16.6.2.2.2. Bag Valve Masks

16.6.2.2.3. Nasal Cannulas

16.6.2.2.4. Venturi Mask

16.6.2.2.5. Others

16.6.2.3. Argentina Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

16.6.2.3.1. Hospitals and Clinics

16.6.2.3.2. Home Healthcare

16.6.2.3.3. Rehabilitation Centers

16.6.2.4. Argentina Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

16.6.2.4.1. COPD (Chronic Obstructive Pulmonary Disease)

16.6.2.4.2. Asthma

16.6.2.4.3. Sleep Apnea

16.6.2.4.4. Respiratory Distress Syndrome (RDS)

16.6.2.4.5. Cystic Fibrosis Pneumonia

16.6.2.4.6. Others

16.6.3. Rest of Latin America

16.6.3.1. Rest of Latin America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Source Equipment

16.6.3.1.1. Oxygen Concentrators

16.6.3.1.2. Compressed Oxygen Cylinders

16.6.3.1.3. Liquid Oxygen Systems

16.6.3.2. Rest of Latin America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Oxygen Delivery Devices

16.6.3.2.1. Oxygen Masks

16.6.3.2.2. Bag Valve Masks

16.6.3.2.3. Nasal Cannulas

16.6.3.2.4. Venturi Mask

16.6.3.2.5. Others

16.6.3.3. Rest of Latin America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By End Users

16.6.3.3.1. Hospitals and Clinics

16.6.3.3.2. Home Healthcare

16.6.3.3.3. Rehabilitation Centers

16.6.3.4. Rest of Latin America Oxygen Therapy Market Revenue (US$ Mn) and Forecasts, By Application

16.6.3.4.1. COPD (Chronic Obstructive Pulmonary Disease)

16.6.3.4.2. Asthma

16.6.3.4.3. Sleep Apnea

16.6.3.4.4. Respiratory Distress Syndrome (RDS)

16.6.3.4.5. Cystic Fibrosis Pneumonia

16.6.3.4.6. Others

16.7. Key Segment for Channeling Investments

16.7.1. By Country

16.7.2. By Oxygen Source Equipment

16.7.3. By Oxygen Delivery Devices

16.7.4. By End Users

16.7.5. By Application

17. Competitive Benchmarking

17.1. Market Share Analysis, 2018

17.2. Global Presence and Growth Strategies

17.2.1. Mergers and Acquisitions

17.2.2. Product Launches

17.2.3. Investments Trends

17.2.4. R&D Initiatives

18. Player Profiles

18.1. 3M

18.1.1. Company Details

18.1.2. Company Overview

18.1.3. Product Offerings

18.1.4. Key Developments

18.1.5. Financial Analysis

18.1.6. SWOT Analysis

18.1.7. Business Strategies

18.2. Chart

18.2.1. Company Details

18.2.2. Company Overview

18.2.3. Product Offerings

18.2.4. Key Developments

18.2.5. Financial Analysis

18.2.6. SWOT Analysis

18.2.7. Business Strategies

18.3. DeVilbiss Healthcare

18.3.1. Company Details

18.3.2. Company Overview

18.3.3. Product Offerings

18.3.4. Key Developments

18.3.5. Financial Analysis

18.3.6. SWOT Analysis

18.3.7. Business Strategies

18.4. Essex Industries, Inc.

18.4.1. Company Details

18.4.2. Company Overview

18.4.3. Product Offerings

18.4.4. Key Developments

18.4.5. Financial Analysis

18.4.6. SWOT Analysis

18.4.7. Business Strategies

18.5. Fisher and Paykel Healthcare Limited

18.5.1. Company Details

18.5.2. Company Overview

18.5.3. Product Offerings

18.5.4. Key Developments

18.5.5. Financial Analysis

18.5.6. SWOT Analysis

18.5.7. Business Strategies

18.6. General Electric Company

18.6.1. Company Details

18.6.2. Company Overview

18.6.3. Product Offerings

18.6.4. Key Developments

18.6.5. Financial Analysis

18.6.6. SWOT Analysis

18.6.7. Business Strategies

18.7. Inogen

18.7.1. Company Details

18.7.2. Company Overview

18.7.3. Product Offerings

18.7.4. Key Developments

18.7.5. Financial Analysis

18.7.6. SWOT Analysis

18.7.7. Business Strategies

18.8. Inotec AMD Limited.

18.8.1. Company Details

18.8.2. Company Overview

18.8.3. Product Offerings

18.8.4. Key Developments

18.8.5. Financial Analysis

18.8.6. SWOT Analysis

18.8.7. Business Strategies

18.9. Invacare Corporation

18.9.1. Company Details

18.9.2. Company Overview

18.9.3. Product Offerings

18.9.4. Key Developments

18.9.5. Financial Analysis

18.9.6. SWOT Analysis

18.9.7. Business Strategies

18.10. Koninklijke PhilipsN.V.

18.10.1. Company Details

18.10.2. Company Overview

18.10.3. Product Offerings

18.10.4. Key Developments

18.10.5. Financial Analysis

18.10.6. SWOT Analysis

18.10.7. Business Strategies

18.11. MAQUET Holding B.V. and Co.KG

18.11.1. Company Details

18.11.2. Company Overview

18.11.3. Product Offerings

18.11.4. Key Developments

18.11.5. Financial Analysis

18.11.6. SWOT Analysis

18.11.7. Business Strategies

18.12. Nidek Medical Products Inc.

18.12.1. Company Details

18.12.2. Company Overview

18.12.3. Product Offerings

18.12.4. Key Developments

18.12.5. Financial Analysis

18.12.6. SWOT Analysis

18.12.7. Business Strategies

18.13. O2 CONCEPTS, LLC

18.13.1. Company Details

18.13.2. Company Overview

18.13.3. Product Offerings

18.13.4. Key Developments

18.13.5. Financial Analysis

18.13.6. SWOT Analysis

18.13.7. Business Strategies

18.14. OxyBand Technologies

18.14.1. Company Details

18.14.2. Company Overview

18.14.3. Product Offerings

18.14.4. Key Developments

18.14.5. Financial Analysis

18.14.6. SWOT Analysis

18.14.7. Business Strategies

18.15. ResMed

18.15.1. Company Details

18.15.2. Company Overview

18.15.3. Product Offerings

18.15.4. Key Developments

18.15.5. Financial Analysis

18.15.6. SWOT Analysis

18.15.7. Business Strategies

18.16. Teleflex Incorporated

18.16.1. Company Details

18.16.2. Company Overview

18.16.3. Product Offerings

18.16.4. Key Developments

18.16.5. Financial Analysis

18.16.6. SWOT Analysis

18.16.7. Business Strategies

18.17. VitalAire

18.17.1. Company Details

18.17.2. Company Overview

18.17.3. Product Offerings

18.17.4. Key Developments

18.17.5. Financial Analysis

18.17.6. SWOT Analysis

18.17.7. Business Strategies

18.18. Other Market Participants

19. Key Findings

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

**Exclusive for Multi-User and Enterprise User.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.

Prominent participants in our primary research process include:

Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources: